Home › Compare › OPYGY vs JNJ

OPYGY vs JNJ: Dividend Comparison 2026

OPYGY yields 21.67% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OPYGY wins by $3.6K in total portfolio value
10 years
OPYGY
OPYGY
● Live price
21.67%
Share price
$21.00
Annual div
$4.55
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$2.54
Full OPYGY calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — OPYGY vs JNJ

📍 OPYGY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOPYGYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OPYGY + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
OPYGY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OPYGY
Annual income on $10K today (after 15% tax)
$1,841.67/yr
After 10yr DRIP, annual income (after tax)
$2.16/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $701.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OPYGY + JNJ for your $10,000?

OPYGY: 50%JNJ: 50%
100% JNJ50/50100% OPYGY
Portfolio after 10yr
$21.8K
Annual income
$415.16/yr
Blended yield
1.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OPYGY
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OPYGY buys
0
JNJ buys
0
No recent congressional trades found for OPYGY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOPYGYJNJ
Forward yield21.67% ✓3.36%
Annual dividend / share$4.55$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR-50%5.8% ✓
Portfolio after 10y$23.6K ✓$20.0K
Annual income after 10y$2.54$827.78 ✓
Total dividends collected$2.3K$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OPYGY vs JNJ ($10,000, DRIP)

YearOPYGY PortfolioOPYGY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,783$1,083.33$10,676$355.77+$1.1K → OPYGY
2$13,205$596.51$11,407$389.39+$1.8K → OPYGY
3$14,441$312.36$12,198$426.53+$2.2K → OPYGY
4$15,612$159.64$13,056$467.62+$2.6K → OPYGY
5$16,785$80.64$13,987$513.12+$2.8K → OPYGY
6$18,001$40.52$14,998$563.56+$3.0K → OPYGY
7$19,281$20.30$16,098$619.52+$3.2K → OPYGY
8$20,641$10.16$17,295$681.69+$3.3K → OPYGY
9$22,091$5.08$18,599$750.82+$3.5K → OPYGY
10$23,640$2.54$20,022$827.78+$3.6K → OPYGY

OPYGY vs JNJ: Complete Analysis 2026

OPYGY — Stock

Public Joint Stock Company Polyus, together with its subsidiaries, engages in the extraction, refining, and sale of gold. The company has primary operations in Krasnoyarsk, Irkutsk, Magadan, and Amur regions, as well as the Republic of Sakha in Russia. It also engages in the research and exploration works. The company was founded in 2005 and is based in Moscow, Russia.

Full OPYGY Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this OPYGY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OPYGY vs SCHDOPYGY vs JEPIOPYGY vs OOPYGY vs KOOPYGY vs MAINOPYGY vs ABBVOPYGY vs MRKOPYGY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.